Status:

COMPLETED

TAKO-TSUBO Cardiomyopathy and Genetic

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Fédération Française de Cardiologie

Conditions:

Tako-TSUBO Cardiomyopathy

Acute Coronary Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

This is a case-control association study with multicentric prospective recruitment. Tako-TSUBO cardiomyopathy is a new clinical entity mimicking an acute coronary syndrome. It is characterized by rev...

Detailed Description

We hypothesize that polymorphisms in the genes involved in the adrenergic pathway resulting in greater catecholamine sensitivity would be associated with an increased risk of Tako-TSUBO cardiomyopathy...

Eligibility Criteria

Inclusion

  • "Tako-TSUBO" group:
  • Inclusion criteria :
  • Patients presenting with Tako-TSUBO cardiomyopathy defined as: 1) an acute chest pain during a stressful incident associated with ST-segment abnormalities and/or increased serum troponin level, 2) transient left ventricular systolic dysfunction, and 3) no coronary lesions related to the left ventricular dysfunction
  • Age \> 18
  • Written consent
  • Caucasian origin
  • Affiliation to health care system
  • Exclusion criteria :
  • Patients presenting with pheochromocytoma
  • Patients presenting with myocarditis
  • Patients presenting with subarachnoid hemorrhage
  • "Acute coronary syndrome" group (age- and sex-matched control group):
  • Inclusion criteria :
  • Patients presenting with an acute coronary syndrome (according to the definitions of guidelines)
  • Age \> 18
  • written consent
  • Caucasian origin
  • Affiliation to health care system
  • Exclusion criteria :
  • Patients presenting with a suspicion of Tako-TSUBO cardiomyopathy
  • Patients presenting with a history of Tako-TSUBO cardiomyopathy
  • "Surgical stress" group (age- and sex-matched control group):
  • Inclusion criteria :
  • Patients hospitalized for an urgent surgery
  • Age \> 18
  • Written consent
  • Caucasian origin
  • Affiliation to health care system
  • Exclusion criteria :
  • Patients presenting with increase of troponin after surgery
  • Patients presenting with ECG abnormalities after surgery
  • Patients presenting with a suspicion of Tako-TSUBO cardiomyopathy
  • Patients presenting with a history of Tako-TSUBO cardiomyopathy

Exclusion

    Key Trial Info

    Start Date :

    November 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2016

    Estimated Enrollment :

    530 Patients enrolled

    Trial Details

    Trial ID

    NCT01520610

    Start Date

    November 1 2011

    End Date

    May 1 2016

    Last Update

    September 15 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Name: Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Ambroise Paré. Université de Versailles-Saint Quentin en Yvelines

    Boulogne-Billancourt, Hautes Des Seine, France, 92210